97 results on '"Habermann, Thomas M."'
Search Results
2. Post-Transplantation Lymphoproliferative Disorders in Adults
3. MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia
4. A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts
5. Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study
6. Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402
7. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types
8. Risk of cutaneous T‐cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non‐Hodgkin lymphoma
9. Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment‐naïve patients with Waldenstrom macroglobulinemia
10. Clinical heterogeneity of diffuse large B cell lymphoma following failure of front‐line immunochemotherapy
11. Long‐term analysis of phase II studies of single‐agent lenalidomide in relapsed/refractory mantle cell lymphoma
12. Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016
13. Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma
14. Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era
15. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011
16. Response-adapted therapy for aggressive non-Hodgkinʼs lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404)
17. Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma
18. Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma
19. The utility of restaging bone marrow biopsy in PET-negative patients with diffuse large B-cell lymphoma and baseline bone marrow involvement
20. A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era
21. Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma
22. Anthropometric, medical history and lifestyle risk factors for myeloproliferative neoplasms in The Iowa Womenʼs Health Study cohort
23. Clinical epidemiology and treatment patterns of patients with multicentric Castleman disease: results from two US treatment centres
24. Lymphoma-associated skin cancer: incidence, natural history, and clinical management
25. Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: Results from two independent cohorts
26. Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients
27. Single-agent lenalidomide is active in patients with relapsed or refractory aggressive non-Hodgkin lymphoma who received prior stem cell transplantation
28. A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma
29. trans Fatty Acid Intake Is Associated with Increased Risk and n3 Fatty Acid Intake with Reduced Risk of Non-Hodgkin Lymphoma1-3
30. Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: A clinic-based case-control study
31. The clinical spectrum of Castlemanʼs disease
32. Food-frequency questionnaire-based estimates of total antioxidant capacity and risk of non-Hodgkin lymphoma
33. Secondary Epstein-Barr virus associated lymphoproliferative disorder developing in a patient with angioimmunoblastic T cell lymphoma on vorinostat
34. Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma
35. Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients
36. Inherited genetic variation and overall survival following follicular lymphoma
37. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphoma
38. Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma
39. ASH 2010 meeting report-top 10 clinically oriented abstracts in lymphoma
40. Patients With Celiac Disease and B-Cell Lymphoma Have a Better Prognosis Than Those With T-Cell Lymphoma
41. Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E-IPI)
42. Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines
43. Smoking, Alcohol Use, Obesity, and Overall Survival From Non-Hodgkin Lymphoma: A Population-Based Study
44. ASH 2009 meeting report—Top 10 clinically oriented abstracts in lymphoma
45. Antioxidant intake from fruits, vegetables and other sources and risk of non-Hodgkinʼs lymphoma: the Iowa Womenʼs Health Study
46. Complementary and alternative medicine use among long-term lymphoma survivors: A pilot study
47. Association of Resident Fatigue and Distress With Perceived Medical Errors
48. Risk of non-Hodgkin lymphoma in association with germline variation in complement genes
49. Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma
50. Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.